The Warren Center for Neuroscience Drug Discovery at Vanderbilt University (WCNDD) extends traditional academic pursuits in basic science to take the most exciting advances in our understanding of human disease and drug targets to a point where these breakthroughs can directly impact patient care. The most innovative and potentially high impact new approaches for treatment of human disease that arise from academic basic science efforts are often untested and pose unacceptable risks for investment of the tremendous capital required to discover and develop a new drug in an industry setting. This is especially true in discovery of new treatment strategies for the most serious of brain disorders, such as Alzheimer’s disease, Parkinson’s disease, schizophrenia, autism, and others. By incorporating the highest level of drug discovery into academic research, we are able to advance the most exciting scientific breakthroughs beyond the lab and toward the development of patentable and marketable drugs suited for clinical studies.

Neuroscience

Therapeutics

Warren Center for Neuroscience Drug Discovery

Warren Center for Neuroscience Drug Discovery's headquarters in Franklin, TN, United States

Description

People (20)

Nathan Kett

Christopher Presley

Colleen Niswender

Hyekyung K. Plumley

Kristen Gilliland

Olivier Boutaud

Alice Rodriguez

Andrew Burns

Anthony Ferranti

Xia Lei

Aaron Bender

Srinivasan K.

Upendra Rathnayake

Ali Gregro

Natalie Lyndon

Darren Engers

Elizabeth Childress

Lisa Barbaro

Claudia Orsburn

John Veillette

Jobs